Search

Your search keyword '"Schluep M"' showing total 252 results

Search Constraints

Start Over You searched for: Author "Schluep M" Remove constraint Author: "Schluep M"
252 results on '"Schluep M"'

Search Results

1. In-depth assessment of health-related quality of life after in-hospital cardiac arrest

2. In-depth assessment of health-related quality of life after in-hospital cardiac arrest

7. Resuscitation Outcomes in the Netherlands: or ROUTINE- project

8. Between-centre differences in care for in-hospital cardiac arrest:a prospective cohort study

10. Neurological outcome after extracorporeal cardiopulmonary resuscitation for in-hospital cardiac arrest: a systematic review and meta-analysis

11. A cross-sectional investigation of communication in Do-Not-Resuscitate orders in Dutch hospitals

15. A cross-sectional investigation of communication in Do-Not-Resuscitate orders in Dutch hospitals

17. Cost-effectiveness of extracorporeal cardiopulmonary resuscitation after in-hospital cardiac arrest

18. Cardiopulmonary resuscitation practices in the Netherlands: results from a nationwide survey

19. Between-centre differences in care for in-hospital cardiac arrest: a prospective cohort study.

22. Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study

23. Preserved decision making ability in early multiple sclerosis

25. The Combined Quantification and Interpretation of Multiple Quantitative Magnetic Resonance Imaging Metrics Enlightens Longitudinal Changes Compatible with Brain Repair in Relapsing-Remitting Multiple Sclerosis Patients

28. Oral fingolimod in primary progressive multiple sclerosis (INFORMS): a phase 3, randomised, double-blind, placebo-controlled trial

29. A Placebo-Controlled Trial of Oral Cladribine for Relapsing Multiple Sclerosis

30. Elevated levels of MIC-1/GDF15 in the cerebrospinal fluid of patients are associated with glioblastoma and worse outcome

32. Multiple Sclerosis lesion fingerprint using multicontrast MRI

33. Cerebellar connectomics provide new biomarkers in early multiple sclerosis

34. [New treatment options in multiple sclerosis and their complications]

37. Health-related quality of life in multiple sclerosis: Effects of natalizumab

39. Minocycline added to subcutaneous interferon β-1a in multiple sclerosis: randomized RECYCLINE study.

41. Detection of oligoclonal free kappa chains in the absence of oligoclonal IgG in the CSF of patients with suspected multiple sclerosis.

46. Cerebrospinal fluid in the diagnosis of multiple sclerosis: a consensus report

47. Gene Therapy for Amyotrophic Lateral Sclerosis (ALS) Using a Polymer Encapsulated Xenogenic Cell Line Engineered to Secrete hCNTF. Lausanne University Medical School, Lausanne, Switzerland

48. Cerebrospinal fluid in the diagnosis of multiple sclerosis: a consensus report.

50. Strong EBV-specific CD8+ T-cell response in patients with early multiple sclerosis.

Catalog

Books, media, physical & digital resources